Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Kura Oncology Inc’s stock clocked out at $5.63, down -5.70% from its previous closing price of $5.97. In other words, the price has decreased by -$5.70 from its previous closing price. On the day, 1.79 million shares were traded. KURA stock price reached its highest trading level at $5.86 during the session, while it also had its lowest trading level at $5.5.
Ratios:
To gain a deeper understanding of KURA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.40. For the most recent quarter (mrq), Quick Ratio is recorded 9.46 and its Current Ratio is at 9.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $27.
Stifel Downgraded its Buy to Hold on October 14, 2024, whereas the target price for the stock was revised from $26 to $19.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 21 ’25 when Hasnain Faheem sold 22,682 shares for $8.00 per share. The transaction valued at 181,456 led to the insider holds 23,983 shares of the business.
FAHEEM HASNAIN bought 30,000 shares of KURA for $235,500 on Mar 21 ’25. On Jan 28 ’25, another insider, DOYLE THOMAS JAMES, who serves as the SVP, Finance & Accounting of the company, sold 4,949 shares for $7.87 each. As a result, the insider received 38,958 and left with 88,193 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 454650656 and an Enterprise Value of -235154272. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.44 while its Price-to-Book (P/B) ratio in mrq is 1.06. Its current Enterprise Value per Revenue stands at -4.364 whereas that against EBITDA is 1.223.
Stock Price History:
The Beta on a monthly basis for KURA is 0.52, which has changed by -0.71098566 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, KURA has reached a high of $23.48, while it has fallen to a 52-week low of $5.41. The 50-Day Moving Average of the stock is -25.00%, while the 200-Day Moving Average is calculated to be -60.01%.
Shares Statistics:
It appears that KURA traded 1.45M shares on average per day over the past three months and 1334990 shares per day over the past ten days. A total of 78.23M shares are outstanding, with a floating share count of 75.15M. Insiders hold about 6.94% of the company’s shares, while institutions hold 96.04% stake in the company. Shares short for KURA as of 1741910400 were 9022023 with a Short Ratio of 6.07, compared to 1739491200 on 9249137. Therefore, it implies a Short% of Shares Outstanding of 9022023 and a Short% of Float of 11.2799995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
